Default object view. Click to create a custom template, Node ID: 104689, Object ID: 62698

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses

No relation

Yes

No relation

No

26/02/2015 4:23 pm

No